Viewing nowCojasal Tablet 100 mg (Losartan Potassium)
Losartan Potassium 100mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

MFDS item code 201705799 · Approved 2017.07.20 · Insurance code 656004640
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication effectively lowers blood pressure in patients with hypertension, thereby reducing the risk of cardiovascular diseases. Additionally, it helps slow the progression of kidney disease in patients with hypertension and type 2 diabetes. It is used for the prevention of various complications related to blood pressure control.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and given orally twice daily, or the dose may be increased to 100 mg once daily if necessary. 3) If blood pressure is not controlled with this medicine alone, it may be used in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be used in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg once daily is recommended. 3) Patients with reduced effective intravascular volume An initial dose of 25 mg once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics) (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh at least 20 kg but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 50 mg once daily. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 100 mg once daily. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially during the second and third trimesters; therefore, pregnant women should not take it. If pregnancy is confirmed, this medication should be discontinued immediately, and care should be taken as it may affect the health of the fetus and newborn. Patients with certain conditions or those who have previously shown allergic reactions to this medication or its ingredients should not take it. Patients with severely impaired liver function or hereditary lactase deficiency should also avoid this medication. Elderly patients, those with weakened kidney function, and patients with hyperkalemia should use this medication with caution and have their blood pressure or kidney function monitored regularly. This medication lowers blood pressure, which may lead to dizziness or hypotension symptoms at the start of treatment or when increasing the dose, so caution is advised. If severe hypotension or renal failure symptoms occur, consult a doctor immediately, and in severe cases, the medication may need to be discontinued. It is advisable not to take potassium supplements or potassium-rich foods without consulting a doctor while on this medication. Additionally, there may be interactions with other drugs, so inform your doctor about any medications you are currently taking. Side effects may include headache, dizziness, muscle pain, indigestion, cough, etc., and if abnormal symptoms persist, consult a doctor. Women who are pregnant or planning to become pregnant should consult a doctor before taking this medication and breastfeeding women should avoid taking it. This medication is not used in children under the age of 6 as its safety and efficacy have not been adequately established. It should be stored out of reach of children and it is advisable not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is also recommended to store the medication at room temperature between 1°C and 30°C, away from extreme heat or cold. Proper storage helps maintain the efficacy of the medication for an extended period.
White, drop-shaped film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 100mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.